SRPT Insider Trading

Insider Ownership Percentage: 7.40%
Insider Buying (Last 12 Months): $10,735,889.18
Insider Selling (Last 12 Months): $4,340,219.33

Sarepta Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Sarepta Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sarepta Therapeutics Share Price & Price History

Current Price: $115.62
Price Change: Price Decrease of -0.93 (-0.80%)
As of 04/19/2024 01:00 AM ET

This chart shows the closing price history over time for SRPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Sarepta Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2024Kathryn Jean BoorDirectorSell761$122.93$93,549.737,516View SEC Filing Icon  
3/8/2024Hans Rudolf WigzellDirectorSell15,000$123.25$1,848,750.0022,840View SEC Filing Icon  
3/5/2024Stephen MayoDirectorSell3,135$122.96$385,479.606,621View SEC Filing Icon  
3/1/2024Bilal ArifInsiderSell2,000$128.84$257,680.0026,836View SEC Filing Icon  
3/1/2024Ian Michael EstepanCFOSell1,200$128.30$153,960.0039,114View SEC Filing Icon  
11/3/2023Douglas S. IngramCEOBuy25,225$79.36$2,001,856.00390,307View SEC Filing Icon  
11/3/2023Richard BarryDirectorBuy50,000$78.81$3,940,500.00140,000View SEC Filing Icon  
8/14/2023Michael Andrew ChambersDirectorBuy9,979$109.47$1,092,401.13246,996View SEC Filing Icon  
8/10/2023Michael Andrew ChambersDirectorBuy34,867$106.15$3,701,132.05213,331View SEC Filing Icon  
8/4/2023Hans Rudolf WigzellDirectorSell15,000$106.72$1,600,800.0020,994View SEC Filing Icon  
11/17/2022Stephen MayoDirectorSell858$109.92$94,311.366,387View SEC Filing Icon  
9/14/2022Michael Andrew ChambersDirectorBuy57,100$104.43$5,962,953.00108,178View SEC Filing Icon  
8/19/2022Michael Andrew ChambersDirectorBuy46,170$108.28$4,999,287.6051,078View SEC Filing Icon  
11/24/2021Louise Rodino-KlapacInsiderBuy3,780$79.33$299,867.40View SEC Filing Icon  
11/17/2021Douglas S. IngramCEOBuy25,026$79.94$2,000,578.44View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SRPT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Sarepta Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/19/2024Hudson Capital Management LLC1,700$0.22M0.1%N/A0.002%Search for SEC Filing on Google Icon
4/19/2024Sumitomo Mitsui Trust Holdings Inc.4,381$0.57M0.0%-34.1%0.005%Search for SEC Filing on Google Icon
4/19/2024Handelsinvest Investeringsforvaltning2,059$0.27M0.1%-34.2%0.002%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC261,288$33.83M0.1%-4.5%0.278%Search for SEC Filing on Google Icon
4/16/2024Wealth Enhancement Advisory Services LLC4,996$0.65M0.0%+100.5%0.005%Search for SEC Filing on Google Icon
4/10/2024Atwood & Palmer Inc.3,000$0.39M0.0%-42.2%0.003%Search for SEC Filing on Google Icon
4/9/2024Mather Group LLC.213$28K0.0%N/A0.000%Search for SEC Filing on Google Icon
4/5/2024GAMMA Investing LLC322$42K0.0%+37.0%0.000%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.1,589$0.15M0.0%-13.4%0.002%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.8,816,124$850.14M0.0%+2.8%9.429%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP4,127,610$398.03M0.1%+5.6%4.398%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.184,870$17.83M0.0%-75.1%0.198%Search for SEC Filing on Google Icon
2/28/2024EP Wealth Advisors LLC4,796$0.46M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC451,873$43.57M1.0%+59.8%0.483%Search for SEC Filing on Google Icon
2/26/2024Neo Ivy Capital Management2,038$0.20M0.4%N/A0.002%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC89,219$8.60M0.1%-27.3%0.095%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD739,736$71.33M0.0%-6.1%0.791%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP6,641$0.64M0.1%-2.6%0.007%Search for SEC Filing on Google Icon
2/16/2024Public Employees Retirement System of Ohio37,461$3.61M0.0%-6.7%0.040%Search for SEC Filing on Google Icon
2/15/2024Palo Alto Investors LP200,905$19.37M1.7%+113.7%0.215%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC3,451$0.33M0.2%+47.9%0.004%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc88,125$8.50M0.0%-4.8%0.094%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.8,816,124$850.14M0.0%+2.8%9.424%Search for SEC Filing on Google Icon
2/15/2024Voloridge Investment Management LLC358,548$34.58M0.1%+265.9%0.383%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC301,771$29.10M0.0%+49.9%0.323%Search for SEC Filing on Google Icon
2/15/2024Vident Advisory LLC2,299$0.22M0.0%+13.0%0.002%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC35,211$3.40M0.1%+17.3%0.038%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD739,736$71.33M0.0%-6.1%0.791%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC16,277$1.57M0.1%+33.5%0.017%Search for SEC Filing on Google Icon
2/15/2024Gilder Gagnon Howe & Co. LLC17,612$1.70M0.0%+6.0%0.019%Search for SEC Filing on Google Icon
2/15/2024Great Point Partners LLC80,000$7.71M1.3%+14.0%0.086%Search for SEC Filing on Google Icon
2/15/2024Boxer Capital LLC650,000$62.68M3.1%+8.3%0.695%Search for SEC Filing on Google Icon
2/15/2024Brevan Howard Capital Management LP8,059$0.78M0.0%+329.8%0.009%Search for SEC Filing on Google Icon
2/15/2024Comerica Bank566$55K0.0%-99.5%0.001%Search for SEC Filing on Google Icon
2/14/2024Pathstone Holdings LLC4,610$0.45M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC8,062$0.78M0.3%N/A0.009%Search for SEC Filing on Google Icon
2/14/2024Point72 Hong Kong Ltd4,168$0.40M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/14/2024Point72 Europe London LLP321$31K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/14/2024Creative Planning6,004$0.58M0.0%-74.1%0.006%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC45,062$4.35M0.0%+144.6%0.048%Search for SEC Filing on Google Icon
2/14/2024Frontier Capital Management Co. LLC52,627$5.08M0.1%-14.0%0.056%Search for SEC Filing on Google Icon
2/14/2024Bridgewater Associates LP26,388$2.55M0.0%-47.7%0.028%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG237,286$22.88M0.4%-1.8%0.254%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC4,344,444$418.94M5.8%+7.9%4.644%Search for SEC Filing on Google Icon
2/14/2024Verition Fund Management LLC3,534$0.34M0.0%+24.6%0.004%Search for SEC Filing on Google Icon
2/14/2024Sei Investments Co.56,119$5.41M0.0%-41.8%0.060%Search for SEC Filing on Google Icon
2/14/2024Capital Fund Management S.A.75,696$7.30M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/14/2024Shell Asset Management Co.4,115$0.40M0.0%-23.0%0.004%Search for SEC Filing on Google Icon
2/14/2024Seven Eight Capital LP5,949$0.57M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.21,541$2.08M0.9%+19.6%0.023%Search for SEC Filing on Google Icon
2/14/2024Schroder Investment Management Group26,700$2.58M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/13/2024Platform Technology Partners2,137$0.21M0.1%-31.6%0.002%Search for SEC Filing on Google Icon
2/13/2024Envestnet Asset Management Inc.32,365$3.12M0.0%-9.2%0.035%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp437,566$42.19M0.0%+2.9%0.468%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado10,091$0.97M0.0%+11.7%0.011%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC739$71K0.0%-85.9%0.001%Search for SEC Filing on Google Icon
2/13/2024Capital International Investors4,741,485$457.22M0.1%+160.0%5.068%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP432,350$41.69M0.0%+0.3%0.462%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.184,870$17.83M0.0%-75.1%0.198%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC103,153$9.95M0.0%+39.1%0.110%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 53,320$5.14M0.0%+8.4%0.057%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC4,454$0.43M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System85,512$8.25M0.0%-4.9%0.091%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.216,168$20.85M0.1%-0.9%0.231%Search for SEC Filing on Google Icon
2/12/2024Alpha DNA Investment Management LLC5,832$0.56M0.2%N/A0.006%Search for SEC Filing on Google Icon
2/12/2024Bank of Nova Scotia528,793$50.99M0.1%N/A0.565%Search for SEC Filing on Google Icon
2/12/2024Treasurer of the State of North Carolina39,677$3.83M0.0%-35.9%0.042%Search for SEC Filing on Google Icon
2/12/2024Allianz Asset Management GmbH27,208$2.62M0.0%+3.2%0.029%Search for SEC Filing on Google Icon
2/12/2024Stifel Financial Corp8,132$0.78M0.0%-15.6%0.009%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc207,112$19.97M0.0%+1.2%0.221%Search for SEC Filing on Google Icon
2/12/2024Hsbc Holdings PLC28,513$2.75M0.0%+1,033.7%0.030%Search for SEC Filing on Google Icon
2/9/2024Orion Portfolio Solutions LLC6,973$0.72M0.0%-50.7%0.007%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE7,539$0.73M0.0%+16.1%0.008%Search for SEC Filing on Google Icon
2/9/2024Cambridge Investment Research Advisors Inc.2,944$0.28M0.0%+5.5%0.003%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP3,271$0.32M0.1%N/A0.003%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.214,266$20.66M0.0%-0.7%0.229%Search for SEC Filing on Google Icon
2/9/2024Assetmark Inc.6,667$0.64M0.0%+74.7%0.007%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP67,433$6.50M0.1%N/A0.072%Search for SEC Filing on Google Icon
2/9/2024Corient Private Wealth LLC5,989$0.58M0.0%+47.9%0.006%Search for SEC Filing on Google Icon
2/9/2024Clearbridge Investments LLC151,127$14.57M0.0%N/A0.162%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG276,276$26.64M0.0%+26.5%0.295%Search for SEC Filing on Google Icon
2/9/2024PNC Financial Services Group Inc.1,589$0.15M0.0%-13.4%0.002%Search for SEC Filing on Google Icon
2/9/2024Norges Bank836,849$80.70M0.0%N/A0.895%Search for SEC Filing on Google Icon
2/8/2024Mizuho Markets Americas LLC305,639$29.47M0.8%+24.3%0.327%Search for SEC Filing on Google Icon
2/8/2024Fiera Capital Corp348,212$33.58M0.1%-2.3%0.372%Search for SEC Filing on Google Icon
2/8/2024EFG Asset Management North America Corp.25,134$2.42M0.5%+10.7%0.027%Search for SEC Filing on Google Icon
2/8/2024Beacon Pointe Advisors LLC6,304$0.61M0.0%-6.8%0.007%Search for SEC Filing on Google Icon
2/8/2024Inceptionr LLC3,061$0.30M0.2%-5.1%0.003%Search for SEC Filing on Google Icon
2/8/2024Thornburg Investment Management Inc.40,345$3.89M0.1%+138.2%0.043%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC3,661$0.35M0.0%-40.3%0.004%Search for SEC Filing on Google Icon
2/8/2024Nicholas Investment Partners LP3,329$0.32M0.0%-99.8%0.004%Search for SEC Filing on Google Icon
2/8/2024First Turn Management LLC203,882$19.66M2.8%N/A0.218%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.3,108$0.29M0.0%+65.2%0.003%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.49,539$4.78M0.0%+125.3%0.053%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP224,201$21.62M0.0%+10.3%0.240%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC14,077$1.36M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas18,347$1.77M0.0%-18.5%0.020%Search for SEC Filing on Google Icon
2/7/2024Principal Securities Inc.274$26K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.5,519$0.53M0.0%+44.7%0.006%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.576,412$55.58M0.0%+2.9%0.616%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Sarepta Therapeutics logo
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Read More on Sarepta Therapeutics

Today's Range

Now: $115.62
Low: $114.38
High: $117.74

50 Day Range

MA: $126.52
Low: $115.62
High: $141.53

52 Week Range

Now: $115.62
Low: $55.25
High: $159.89

Volume

641,078 shs

Average Volume

568,956 shs

Market Capitalization

$10.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Sarepta Therapeutics?

Sarepta Therapeutics' top insider investors include:
  1. Douglas S Ingram (CEO)
  2. Michael Andrew Chambers (Director)
  3. Richard Barry (Director)
  4. Ian Michael Estepan (CFO)
  5. Bilal Arif (Insider)
  6. Hans Lennart Rudolf Wigzell (Director)
  7. Kathryn Jean Boor (Director)
  8. Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.

Who are the major institutional investors of Sarepta Therapeutics?

Sarepta Therapeutics' top institutional shareholders include:
  1. Allspring Global Investments Holdings LLC — 0.28%
  2. Wealth Enhancement Advisory Services LLC — 0.01%
  3. Sumitomo Mitsui Trust Holdings Inc. — 0.00%
  4. Atwood & Palmer Inc. — 0.00%
  5. Handelsinvest Investeringsforvaltning — 0.00%
  6. Hudson Capital Management LLC — 0.00%
Learn More about top institutional investors of Sarepta Therapeutics stock.

Which institutional investors are selling Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was sold by these institutional investors:
  1. Allspring Global Investments Holdings LLC
  2. Sumitomo Mitsui Trust Holdings Inc.
  3. Atwood & Palmer Inc.
  4. Handelsinvest Investeringsforvaltning
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
  1. Douglas S Ingram (CEO)
  2. Michael Andrew Chambers (Director)
  3. Richard Barry (Director)
  4. Ian Michael Estepan (CFO)
  5. Bilal Arif (Insider)
Learn More investors selling Sarepta Therapeutics stock.

Which institutional investors are buying Sarepta Therapeutics stock?

During the previous quarter, SRPT stock was bought by institutional investors including:
  1. Wealth Enhancement Advisory Services LLC
  2. Hudson Capital Management LLC
  3. Mather Group LLC.
  4. GAMMA Investing LLC
Within the last year, these company insiders have bought Sarepta Therapeutics stock:
  1. Douglas S Ingram (CEO)
  2. Michael Andrew Chambers (Director)
  3. Richard Barry (Director)
Learn More investors buying Sarepta Therapeutics stock.